J. Lavine
Epidemiology · 2005–2021
A researcher in the Science corpus: 10 papers; trusts 3 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 188 citations into it; #820 of 2,148 by trust here, #127 by citations
Whom J. Lavine trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Lavine overall
Papers from J. Lavine's perspective
Ordered by how strongly the researchers J. Lavine trusts endorse each paper. Same corpus, a different order for every researcher.
- ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
- Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality (Hepatology)
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
- The natural history of nonalcoholic fatty liver disease: a population-based cohort study. (Gastroenterology)
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
- Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
- Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (New England Journal of Medicine)
Their papers
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018) — 6,253 citations
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2014) — 2,063 citations
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012) — 2,216 citations
- The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. (2012) — 1,723 citations
- ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (2011) — 738 citations
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents (2011) — 1,028 citations
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (2010) — 3,032 citations
- Prevalence of Fatty Liver in Children and Adolescents (2006) — 1,491 citations
- Histopathology of pediatric nonalcoholic fatty liver disease (2005) — 745 citations